结构性光体积描记术（SLP）在 2019 冠状病毒病（COVID-19）患者中的可行性。
Feasibility of structured light Plethysmography (SLP) in patients with coronavirus disease 2019 (COVID-19).
机构信息
Cambridge University NHS Foundation Trust, Cambridge, UK.
Thoracic Surgery, Bart's Heart Centre, St Bartholomews Hospital, London, UK.
出版信息
J Cardiothorac Surg. 2021 Mar 3;16(1):20. doi: 10.1186/s13019-021-01395-0.
As a result of the COVID-19 pandemic, most institutions have changed the way patients are assessed or investigated. Using novel non-contact technology, it is possible to continuously monitor the lung function of peri-operative patients undergoing cardiothoracic procedures. Primarily, this results in increased patient surveillance, and therefore, safety. Many centres, globally, are starting to use structured light plethysmography (SLP) technology, providing a non-aerosol generating procedure in place of traditional spirometry. While more evidence is needed, our clinical usage; previous and on-going studies; demonstrate definite potential that SLP is a valuable tool.
由于 COVID-19 大流行，大多数机构已经改变了评估或调查患者的方式。使用新型非接触技术，可以连续监测接受心胸手术的围手术期患者的肺功能。这主要导致了患者监测的增加，从而提高了安全性。全球许多中心开始使用结构光体积描记术（SLP）技术，提供一种非气溶胶产生的程序来替代传统的肺活量测定法。虽然需要更多的证据，但我们的临床应用；以前和正在进行的研究；表明 SLP 具有很大的潜力，是一种有价值的工具。
Zotero 插件